PPP2R2B and breast cancer: In addition to DMFS, PPP2R2B downregulation, among the seven candiates, is also associated with poor RFS (Supplementary Fig. 1a), as well as poor overall survival (OS) in HER2+ breast cancer patients (Supplementary Fig. 1b).